期刊文献+

microRNA在结直肠癌转移中作用机制的研究进展 被引量:2

Advancement in the study of mechanism of microRNA in metastasis of colorectal cancer
下载PDF
导出
摘要 肿瘤细胞转移是由多种因子参与的复杂生物学行为,microRNA(miRNA)作为其中的重要因子,参与转移过程中的调控。结直肠癌患者中,转移引起的并发症是其主要死因。miRNA在结直肠癌转移中作用的研究目前尚处于起步阶段,目前已知其参与抗凋亡、上皮细胞间质化、瘤细胞增值侵袭及新生血管生成等步骤的调控,发挥促进或抑制结直肠癌细胞转移效应。本文就近年miRNA在结直肠癌的转移各通路中的作用与机制的研究进展进行综述,旨在就miRNA在临床诊断治疗的科研提供依据与思路。 The metastasis of tumor cells is a pathological process that comprises multiple factors. microRNA is one of the important parts taking part in the regulation of the process. Complication of metastasis is the major cause of death in eolorectal cancer (CRC). Nowadays research of microRNA in metastisis of CRC still remains inefficient and anti-apoptotis,epithelial-mesenehymal transition,gain of invation as well as angiogenesis is known to be the major regulation method,positive or negative. This review explores recent development in the role of microRNA and its mechanism of CRC metastases which may provide new insights that could be of therapeutic consequence.
出处 《复旦学报(医学版)》 CAS CSCD 北大核心 2013年第1期97-101,共5页 Fudan University Journal of Medical Sciences
基金 国家科技部"国家科技重大新药创制专项"基金项目(2012ZX09303004-001)~~
关键词 microRNA(miRNA) 结直肠癌 转移 microRNA (miRNA) colorectal cancer metastasis
  • 相关文献

参考文献1

二级参考文献32

  • 1Weir HK,Thun MJ,Hankey BF,Ries LA,Howe HL,Wingo PA,Jemal A,Ward E,Anderson RN,Edwards BK.Annual report to the nation on the status of cancer,1975-2000,featuring the uses of surveillance data for cancer prevention and control.J Natl Cancer Inst 2003; 95:1276-1299
  • 2Greenlee RT,Murray T,Bolden S,Wingo PA.Cancer statistics,2000.CA Cancer J Clin 2000; 50:7-33
  • 3August DA,Ottow RT,Sugarbaker PH.Clinical perspective of human colorectal cancer metastasis.Cancer Metastasis Rev 1984; 3:303-324
  • 4Fearon ER,Vogelstein B.A genetic model for colorectal tumorigenesis.Cell 1990; 61:759-767
  • 5Cho KR,Vogelstein B.Genetic alterations in the adenoma--carcinoma sequence.Cancer 1992; 70:1727-1731
  • 6Vogelstein B,Kinzler KW.The multistep nature of cancer.Trends Genet 1993; 9:138-141
  • 7Smith G,Carey FA,Beattie J,Wilkie MJ,Lightfoot TJ,Coxhead J,Garner RC,Steele RJ,Wolf CR.Mutations in APC,Kirsten-ras,and p53--alternative genetic pathways to colorectal cancer.Proc Natl Acad Sci USA 2002; 99:9433-9438
  • 8Ambros V.microRNAs:tiny regulators with great potential.Cell 2001; 107:823-826
  • 9Bartel DP.MicroRNAs:genomics,biogenesis,mechanism,and function.Cell 2004; 116:281-297
  • 10Carrington JC,Ambros V.Role of microRNAs in plant and animal development.Science 2003; 301:336-338

共引文献39

同被引文献13

  • 1宋恕平.结直肠癌的内科治疗及进展[J].中华肿瘤防治杂志,2006,13(14):1041-1042. 被引量:15
  • 2Hamada H, Garcia-Hemandez MdeL, Reome JB, et al. Tcl7, a unique subset of CD8 T cells that can protect against lethal influenza challenge [ J ]. J Immuno1,2009,182 (6) :3469-3481.
  • 3Huber M, Heiuk S, Grothe H, et al. A Thl7-1ike developmental process leads to CD8+ Tc17 cells with reduced cytotoxic activity [ J ]. Eur J Immuno1,2009,39 (7) : 1716-1725.
  • 4Ciric B, El-behi M, Cabrera R, et al. IL-23 drives pathogenic IL- 17-producing CD8 T ceils [ J ]. J Immunol, 2009, 182 ( 9 ) : 5296-5305.
  • 5Zhuang Y,Peng LS,Zhao YL,et al. CD8 (+) T cells that produce interleukin-17 regulate myeloid-derived suppressor cells and are associated with survival time of patients with gastric cancer [ J ]. Gastroenterology,2012,143 ( 4 ) : 951-62. e8.
  • 6Li J, Huang ZF,Xiong G,et al. Distribution, characterization, and induction of CD8 regulatory T cells and IL-17-producing CD8 T cells in nasopharyngeal carcinoma [ J ]. J Transl Med, 2011, 9:189.
  • 7Liu SJ,Tsai JP,Shen CR,et al. Induction of a distinct CD8 The 17 subset by transforming growth factor-beta and intedeukin-6 [ J ]. J Leukoc Bio1,2007,82 ( 2 ) :354-360.
  • 8Loekhart E, Green AM, Flynn ../L. IL-17 production is dominated by gamraadelta T cells rather than CIM T cells during Mycobacterium tuberculosis infection [ J ]. J Immunol,2006,177 ( 7 ) :4662-4669.
  • 9Dwivedi VP,Tousif S, Bhattacharya D, et al. Transforming growth factor-13 protein inversely regulates in vivo differentiation of interleukin-17 ( IL-17 ) -producing CD4+ and CD8+ T cells [ J]. J Biol Chem ,2012,287 (5) :2943-2947.
  • 10Kuang DM, Peng C, Zhao Q, et al. Tumor-activated monocytes promole expansion of IL-17-producing CD8+ T cells in hepatocellular carcinoma patients [ J]. J Immunol, 2010, 185 (3) :1544-1549.

引证文献2

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部